<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02416063</url>
  </required_header>
  <id_info>
    <org_study_id>Faculty of medicine-JU</org_study_id>
    <nct_id>NCT02416063</nct_id>
  </id_info>
  <brief_title>Caudal Versus Intravenous Dexmedetomidine for Caudal Analgesia in Children</brief_title>
  <official_title>Caudal Versus Intravenous Dexmedetomidine for Caudal Analgesia in Children: A Randomised Controlled Double Blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Jordan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Jordan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this prospective randomized double-blind study was to compare the analgesic
      efficacy and the side effects of dexmedetomidine (1 µg.kg-1) co-administered with bupivacaine
      for caudal analgesia or intravenously in children undergoing infra-umbilical surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dexmedetomidine is used increasingly in pediatric anesthesia practice to prolong the duration
      of action of caudal block with a local anesthetic agent.But which route of administration of
      dexmedetomidine is the most beneficial remains unknown.

      The investigators performed prospective randomized double-blind study to compare the effects
      of caudal dexmedetomidine with intravenous dexmedetomidine on postoperative analgesia after
      caudal bupivacaine in children undergoing infra-umbilical surgery.

      75 children (ASAⅠorⅡ,aged 1-6 yr) undergoing infra-umbilical surgery were included in this
      study. Anesthesia was induced with sevoflurane via a facemask, followed by placement of a
      laryngeal mask airway. Anesthesia was maintained with sevoflurane 2-3% in
      oxygen-air.Then,caudal block was applied. Patients were randomly assigned in three groups.
      Group B-Dcau (n = 25): Caudal bupivacaine 0.25% 1ml/kg plus dexmedetomidine 1µg/kg and 10 ml
      normal saline i.v.;Group B-Div (n = 25): bupivacaine 0.25% 1ml/kg and dexmedetomidine
      1µg/kg(10 ml)i.v.;Group B(n = 25): bupivacaine 0.25% and 10 ml normal saline intravenous
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to first analgesic requirement</measure>
    <time_frame>24 hours</time_frame>
    <description>Time to first rescue medication. The time from end of surgery to the first requirement of postoperative analgesia,pain score ≥4</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative behaviour scores</measure>
    <time_frame>2 hours</time_frame>
    <description>behaviour score was recorded throughout the post-anesthesia care unit stay at 15-minute time intervals.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sevoflurane concentration</measure>
    <time_frame>1 hour</time_frame>
    <description>Sevoflurane concentration required to maintain Bispectral Index (BIS) monitor reading between 40 and 60</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure Perioperative blood pressure readings</measure>
    <time_frame>2 hours</time_frame>
    <description>Perioperative blood pressure readings</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>2 hours</time_frame>
    <description>Perioperative heart rate readings</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the incidence of emergence agitation</measure>
    <time_frame>2 hours</time_frame>
    <description>Participants will be followed for the duration of PACU stay, an expected average of 2 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain scores</measure>
    <time_frame>24 hours</time_frame>
    <description>postoperative pain score will be assessed over 24 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
    <time_frame>24 hours</time_frame>
    <description>side effects including nausea, vomiting and urinary retention and lower limb weakness</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>caudal Dexmedetomidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Drug:Caudal Bupivacaine 0.25% 1ml/kg .
Drug:caudal Dexmedetomidine 1μg /kg.
Intravenous :10 ml normal saline
Anesthesia was induced and maintained with sevoflurane</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intravenous Dexmedetomidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Drug:Caudal bupivacaine 0.25% 1ml/kg
Drug: Intravenous dexmedetomidine 1µg/kg in a 10 ml volume normal saline
Anesthesia was induced and maintained with sevoflurane</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Caudal: bupivacaine 0.25% 1ml/kg .
Intravenous: 10 ml Normal saline
Anesthesia was induced and maintained with sevoflurane</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Caudal Dexmedetomidine</intervention_name>
    <description>Drug:Caudal bupivacaine 0.25% 1ml/kg
Drug: Caudal dexmedetomidine 1µg/kg
Intravenous: 10 ml normal saline
sevoflurane Induction and maintenance of anesthesia</description>
    <arm_group_label>caudal Dexmedetomidine</arm_group_label>
    <other_name>dexmedetomidine</other_name>
    <other_name>Precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous dexmedetomidine</intervention_name>
    <description>Drug:Caudal bupivacaine 0.25% 1ml/kg.
Drug:Intravenous dexmedetomidine1 μg /kg in a total volume of 10 ml
sevoflurane Induction and maintenance of anesthesia</description>
    <arm_group_label>Intravenous Dexmedetomidine</arm_group_label>
    <other_name>precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Drug:Caudal bupivacaine 0.25% 1ml/kg
Intravenous: Normal saline 10 ml
sevoflurane Induction and maintenance of anesthesia</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>normal saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with American Society of Anesthesiologists (ASA) - I

          -  Scheduled for lower abdominal and perineal surgery

          -  Under general anesthesia

        Exclusion Criteria:

          -  Hypersensitivity to any local anesthetics

          -  Patient has history of allergy, intolerance, or reaction to dexmedetomidine

          -  Infections at puncture sites

          -  Bleeding diathesis

          -  Preexisting neurological disease

          -  Children with uncorrected cardiac lesions

          -  Children with heart block
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>khaled R Al-zaben</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Jordan</affiliation>
  </overall_official>
  <reference>
    <citation>Zhang C, Hu J, Liu X, Yan J. Effects of intravenous dexmedetomidine on emergence agitation in children under sevoflurane anesthesia: a meta-analysis of randomized controlled trials. PLoS One. 2014 Jun 16;9(6):e99718. doi: 10.1371/journal.pone.0099718. eCollection 2014.</citation>
    <PMID>24932765</PMID>
  </reference>
  <reference>
    <citation>Guler G, Akin A, Tosun Z, Ors S, Esmaoglu A, Boyaci A. Single-dose dexmedetomidine reduces agitation and provides smooth extubation after pediatric adenotonsillectomy. Paediatr Anaesth. 2005 Sep;15(9):762-6.</citation>
    <PMID>16101707</PMID>
  </reference>
  <reference>
    <citation>Al-Zaben KR, Qudaisat IY, Al-Ghanem SM, Massad IM, Al-Mustafa MM, Al-Oweidi AS, Abu-Halaweh SA, Abu-Ali HM, Saleem MM. Intraoperative administration of dexmedetomidine reduces the analgesic requirements for children undergoing hypospadius surgery. Eur J Anaesthesiol. 2010 Mar;27(3):247-52. doi: 10.1097/EJA.0b013e32833522bf.</citation>
    <PMID>19952754</PMID>
  </reference>
  <reference>
    <citation>Kim NY, Kim SY, Yoon HJ, Kil HK. Effect of dexmedetomidine on sevoflurane requirements and emergence agitation in children undergoing ambulatory surgery. Yonsei Med J. 2014 Jan;55(1):209-15. doi: 10.3349/ymj.2014.55.1.209.</citation>
    <PMID>24339309</PMID>
  </reference>
  <reference>
    <citation>She YJ, Xie GT, Tan YH, Kuang XH, Yu GF, Lian GH, Song XR. A prospective study comparing the onset and analgesic efficacy of different concentrations of levobupivacaine with/without dexmedetomidine in young children undergoing caudal blockade. J Clin Anesth. 2015 Feb;27(1):17-22. doi: 10.1016/j.jclinane.2014.09.005. Epub 2014 Nov 21.</citation>
    <PMID>25468576</PMID>
  </reference>
  <reference>
    <citation>Schnabel A, Reichl SU, Poepping DM, Kranke P, Pogatzki-Zahn EM, Zahn PK. Efficacy and safety of intraoperative dexmedetomidine for acute postoperative pain in children: a meta-analysis of randomized controlled trials. Paediatr Anaesth. 2013 Feb;23(2):170-9. doi: 10.1111/pan.12030. Epub 2012 Oct 9. Review.</citation>
    <PMID>23043461</PMID>
  </reference>
  <reference>
    <citation>Fares KM, Othman AH, Alieldin NH. Efficacy and safety of dexmedetomidine added to caudal bupivacaine in pediatric major abdominal cancer surgery. Pain Physician. 2014 Sep-Oct;17(5):393-400.</citation>
    <PMID>25247897</PMID>
  </reference>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2015</study_first_submitted>
  <study_first_submitted_qc>April 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 14, 2015</study_first_posted>
  <last_update_submitted>April 8, 2015</last_update_submitted>
  <last_update_submitted_qc>April 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Jordan</investigator_affiliation>
    <investigator_full_name>Khaled Radian Al-zaben</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

